Advanced Enzyme Technologies Ltd. (ADVENZYMES)
NSE
Closed
Aug 24, 2026
Day's Range
299.0052 wk Range
251.95Overview - ADVENZYMES - Advanced Enzyme Technologies Ltd.
Key Statistics
Valuation
Enterprise Value
27.36B
P/E (Trailing)
‪20.28‬
P/E (Forward)
‪16.30‬
PEG Ratio
‪16.30‬
Price / Sales (TTM)
‪4.48‬
Price / Book
‪2.05‬
EV / EBITDA
‪12.92‬
Profitability
Gross Margin
‪72.00%‬
Profit Margin
‪22.12%‬
Operating Margin
‪21.64%‬
Return on Assets
‪9.17%‬
Return on Equity
‪10.02%‬
Ownership
Shares Outstanding
111.92M
Float
36.74M
Held by Insiders
‪55.46%‬
Held by Institutions
‪19.42%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪325.68‬
200-Day Avg
‪315.34‬
Dividends
Payout Ratio
‪8.10%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - ADVENZYMES - Advanced Enzyme Technologies Ltd.
Peers - ADVENZYMES - Advanced Enzyme Technologies Ltd.
Peer Comparison
Compared with companies in Specialty Chemicals listed on NSE.
Profile Summary - ADVENZYMES - Advanced Enzyme Technologies Ltd.
About
Advanced Enzyme Technologies Ltd. is a prominent player in the global biotechnology landscape, specializing in the development, manufacturing, and marketing of enzyme-based solutions. The primary function of Advanced Enzyme is to provide innovative applications that improve processes and products across various…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
